Confounders and intermediaries in case–control study designs: a strategy for distinguishing between the two when measured using the same variable
The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy
Validation of the national health insurance research database with ischemic stroke cases in Taiwan
Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database
MAT-CHDSP, a novel medication assessment tool for evaluation of secondary prevention of coronary heart disease
Linkage of mother–baby pairs in the German Pharmacoepidemiological Research Database
Quality and completeness of utilisation data on biological agents across European countries: tumour necrosis factor alpha inhibitors as a case study
Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity
The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case–control study
Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD
Could adverse reactions of antibiotic drugs in children be detected in a prescription database?
Determining the test characteristics of claims-based diagnostic codes for the diagnosis of venous thromboembolism in a medical service claims database
Role of key informants and direct patient interviews in epidemiological studies of substance abuse
Ascertainment of warfarin and aspirin use by medical record review compared with automated pharmacy data
The role of the c -statistic in variable selection for propensity score models
What does validation of cases in electronic record databases mean? The potential contribution of free text†
Review of “The Dawn of Drug Safety” by M. D. B. Stephens
Review of the “the dawn of drug safety” †